KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,654,419 | -9.1% | 7,500,000 | 0.0% | 0.02% | -16.0% |
| Q2 2023 | $5,118,750 | +20.0% | 7,500,000 | +36.4% | 0.02% | +13.6% |
| Q1 2023 | $4,263,913 | +60.5% | 5,500,000 | +57.1% | 0.02% | +15.8% |
| Q4 2022 | $2,656,016 | -6.1% | 3,500,000 | 0.0% | 0.02% | +11.8% |
| Q3 2022 | $2,828,000 | -30.1% | 3,500,000 | -36.4% | 0.02% | -15.0% |
| Q2 2022 | $4,046,000 | -13.2% | 5,500,000 | 0.0% | 0.02% | +53.8% |
| Q1 2022 | $4,660,000 | +3.6% | 5,500,000 | 0.0% | 0.01% | +62.5% |
| Q4 2021 | $4,496,000 | -14.7% | 5,500,000 | -21.4% | 0.01% | -20.0% |
| Q3 2021 | $5,268,000 | -25.0% | 7,000,000 | 0.0% | 0.01% | -37.5% |
| Q2 2021 | $7,021,000 | -49.8% | 7,000,000 | -48.1% | 0.02% | -61.0% |
| Q1 2021 | $13,992,000 | – | 13,500,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 15,000,000 | $15,028,000 | 1.61% |
| Context Capital Management, LLC | 13,000 | $13,039,000 | 1.21% |
| STEELHEAD PARTNERS LLC | 14,000,000 | $13,941,000 | 0.92% |
| PenderFund Capital Management Ltd. | 3,000,000 | $3,754,000 | 0.88% |
| AQR Arbitrage LLC | 7,000,000 | $7,021,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $19,960,000 | 0.16% |
| CSS LLC/IL | 2,000,000 | $1,991,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,000,000 | $10,456,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $17,552,000 | 0.02% |
| Daiwa Securities Group Inc. | 3,000,000 | $3,004,000 | 0.02% |